No significant differences in age at diagnosis (p = 0.488), ki-67 (p = 0.920), presence of bilateral or second primary BC (p = 0.249), histotype (p = 1.00), PR (p = 0.105) or HER2 expression (p = 0.052) were observed. This evidence concerns the gene ERBB2 and breast cancer.